VF
CRDF icon

Virtu Financial’s Cardiff Oncology CRDF Stock Holding History

Virtu Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Sell
13,604
-24,875
-65% -$51.1K ﹤0.01% 1384
2025
Q4 		$108K Buy
+38,479
New +$89.3K ﹤0.01% 1186
2025
Q2 		– Sell
-19,212
Closed -$60K – 1558
2025
Q1 		$60K Sell
19,212
-31,969
-62% -$126K ﹤0.01% 989
2024
Q4 		$222K Buy
+51,181
New +$160K 0.01% 832
2024
Q1 		– Sell
-21,492
Closed -$32K – 1513
2023
Q4 		$32K Buy
+21,492
New +$26K ﹤0.01% 1243
2023
Q1 		– Sell
-39,358
Closed -$55K – 1603
2022
Q4 		$55K Buy
39,358
+5,047
+15% +$7.23K 0.01% 1063
2022
Q3 		$53K Buy
34,311
+21,748
+173% +$52.3K ﹤0.01% 1190
2022
Q2 		$28K Buy
+12,563
New +$21K ﹤0.01% 1266
2021
Q3 		– Sell
-19,925
Closed -$133K – 1575
2021
Q2 		$133K Sell
19,925
-13,330
-40% -$113K 0.01% 1126
2021
Q1 		$308K Buy
+33,255
New +$404K 0.02% 803
2020
Q4 		– Sell
-20,604
Closed -$292K – 1489
2020
Q3 		$292K Buy
+20,604
New +$136K 0.05% 447
2018
Q2 		– Sell
-1,471
Closed -$37K – 2038
2018
Q1 		$37K Buy
1,471
+475
+48% +$11.7K ﹤0.01% 1757
2017
Q4 		$22K Sell
996
-102
-9% -$4.52K ﹤0.01% 2206
2017
Q3 		$58K Buy
+1,098
New +$68.5K ﹤0.01% 2205

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Virtu Financial's CRDF Position: Q1 2026 in Review

Virtu Financial reduced its Cardiff Oncology (CRDF) stake by 65% in Q1 2026, selling an estimated $51.1K and leaving 13,604 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Virtu Financial first reported a position in CRDF in Q3 2017 and has held it in 14 quarters since. The position peaked at $308K in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Virtu Financial held 13,604 shares of Cardiff Oncology worth $22K as of Q1 2026.
  • Virtu Financial sold 24,875 Cardiff Oncology shares in Q1 2026, an estimated $51.1K.
  • Cardiff Oncology made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1384 holding.
  • Virtu Financial first reported a position in Cardiff Oncology in Q3 2017 and has held it in 14 quarters since.
  • Virtu Financial's Cardiff Oncology position peaked at $308K in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.